Insider Transactions in Q1 2021 at Zogenix, Inc. (ZGNX)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,347
-5.36%
|
$26,940
$20.7 P/Share
|
Mar 15
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,531
+15.28%
|
-
|
Mar 15
2021
|
Gail M Farfel Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,864
-4.36%
|
$37,280
$20.7 P/Share
|
Mar 15
2021
|
Gail M Farfel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,156
+10.73%
|
-
|
Mar 15
2021
|
Stephen J Farr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,836
-2.18%
|
$116,720
$20.7 P/Share
|
Mar 15
2021
|
Stephen J Farr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,875
+5.94%
|
-
|
Mar 15
2021
|
Michael P Smith EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-9.47%
|
$36,120
$20.7 P/Share
|
Mar 15
2021
|
Michael P Smith EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,218
+21.4%
|
-
|
Mar 15
2021
|
Bradley S. Galer EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,462
-2.32%
|
$29,240
$20.7 P/Share
|
Mar 15
2021
|
Bradley S. Galer EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,218
+7.64%
|
-
|